156 related articles for article (PubMed ID: 18096249)
1. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
[TBL] [Abstract][Full Text] [Related]
2. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
4. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
Kim SK; Nguyen Pham TN; Nguyen Hoang TM; Kang HK; Jin CJ; Nam JH; Chung SY; Choi SJ; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
Ann Hematol; 2009 Nov; 88(11):1113-23. PubMed ID: 19277657
[TBL] [Abstract][Full Text] [Related]
5. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
6. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
Yoon SH; Cho HI; Kim TG
Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
[TBL] [Abstract][Full Text] [Related]
7. Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.
Melenhorst JJ; Solomon SR; Shenoy A; Hensel NF; McCoy JP; Keyvanfar K; Barrett AJ
J Immunother; 2006; 29(4):436-43; discussion 365-6. PubMed ID: 16799339
[TBL] [Abstract][Full Text] [Related]
8. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL
Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355
[TBL] [Abstract][Full Text] [Related]
9. Activated B cells mediate efficient expansion of rare antigen-specific T cells.
Zentz C; Wiesner M; Man S; Frankenberger B; Wollenberg B; Hillemanns P; Zeidler R; Hammerschmidt W; Moosmann A
Hum Immunol; 2007 Feb; 68(2):75-85. PubMed ID: 17321896
[TBL] [Abstract][Full Text] [Related]
10. Murine model of CD40-activation of B cells.
Liebig TM; Fiedler A; Klein-Gonzalez N; Shimabukuro-Vornhagen A; von Bergwelt-Baildon M
J Vis Exp; 2010 Mar; (37):. PubMed ID: 20208476
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo induction of viral antigen-specific CD8 T cell responses using mRNA-electroporated CD40-activated B cells.
Van den Bosch GA; Ponsaerts P; Nijs G; Lenjou M; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
Clin Exp Immunol; 2005 Mar; 139(3):458-67. PubMed ID: 15730391
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the number of CD154 molecules in membrane extracts used as a source of CD40 stimulation of human B lymphocytes.
Ducas E; Dussault N; Roy A; Dumont N; Néron S
J Immunol Methods; 2009 May; 344(2):133-7. PubMed ID: 19332074
[TBL] [Abstract][Full Text] [Related]
13. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.
Mason NJ; Coughlin CM; Overley B; Cohen JN; Mitchell EL; Colligon TA; Clifford CA; Zurbriggen A; Sorenmo KU; Vonderheide RH
Gene Ther; 2008 Jul; 15(13):955-65. PubMed ID: 18337841
[TBL] [Abstract][Full Text] [Related]
14. A novel immunotherapy to hepatocellular carcinoma: CD40-activated B lymphocytes transfected with AFPmRNA.
Wan Y; Ma X; Li X; Yi J
Med Hypotheses; 2009 Nov; 73(5):835-7. PubMed ID: 19632790
[TBL] [Abstract][Full Text] [Related]
15. B cells can prime naive CD4+ T cells in vivo in the absence of other professional antigen-presenting cells in a CD154-CD40-dependent manner.
Rodríguez-Pinto D; Moreno J
Eur J Immunol; 2005 Apr; 35(4):1097-105. PubMed ID: 15756646
[TBL] [Abstract][Full Text] [Related]
16. Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.
Néron S; Nadeau PJ; Darveau A; Leblanc JF
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):25-40. PubMed ID: 21234809
[TBL] [Abstract][Full Text] [Related]
17. RNA-electroporated CD40-activated B cells induce functional T-cell responses against HepG2 cells.
Shen SN; Xu Z; Qian XP; Ding YT; Yu LX; Liu BR
Eur J Cancer Care (Engl); 2008 Jul; 17(4):404-11. PubMed ID: 18485013
[TBL] [Abstract][Full Text] [Related]
18. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of long-term culture system for human B cells derived from peripheral blood mononuclear cells activated via soluble CD40 ligand].
Wu C; Liu Y; Zhao Q; Chen GM; Chen JH; Yan XM; Zhou YH; Huang ZH
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):124-7. PubMed ID: 19489277
[TBL] [Abstract][Full Text] [Related]
20. A new clinically relevant approach to expand myelin specific T cells.
Arbour N; Lapointe R; Saikali P; McCrea E; Regen T; Antel JP
J Immunol Methods; 2006 Mar; 310(1-2):53-61. PubMed ID: 16464465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]